Ignite Creation Date:
2024-05-06 @ 3:02 AM
Last Modification Date:
2024-10-26 @ 11:27 AM
Study NCT ID:
NCT02191137
Status:
COMPLETED
Last Update Posted:
2017-10-13
First Post:
2014-06-27
Brief Title:
Measuring Outcomes In Patients With Pulmonary Arterial Hypertension Not on Active Treatment MOTION
Sponsor:
Bayer
Organization:
Bayer
Study Overview
Official Title:
A Phase IV Prospective Single-Arm Open-Label Study to Measure Outcomes in Patients With Pulmonary Arterial Hypertension Not on Active Treatment
Status:
COMPLETED
Status Verified Date:
2017-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The MOTION study was a prospective Phase IV study for patients with Pulmonary Arterial Hypertension PAH The study was designed to further explore patient-reported outcomes in PAH subjects who were not on active treatment and living in the United States In addition the study explored the use of new telemetric technology Accelerator band to evaluate if this technology correlates with improvements in 6 Minute Walking Distance 6MWD in patients with PAH
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None